Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med. 2014 Jun; 3(3):592-602.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Brain Neoplasms
Clinical Trials, Phase III as Topic
Disease-Free Survival
Equipment and Supplies
Glioblastoma
Humans
Middle Aged
Mitosis
Neoplasm Recurrence, Local
authors with profiles
Kenneth Dean Swanson, Ph.D.
Eric T. Wong, M.D.